• Nektar Therapeutics (NASDAQ:NKTR) Given Buy Rating at HC Wainwright

    المصدر: Buzz FX / 14 مارس 2025 08:36:17   America/New_York


    Nektar Therapeutics (NASDAQ:NKTR) Given Buy Rating at HC Wainwright Written by MarketBeat March 14, 2025 Share Link copied to clipboard. Remove Ads Nektar Therapeutics ( NASDAQ:NKTR - Get Free Report ) 's stock had its "buy" rating restated
    Read more...
شارك على،